Sort
21,453 grants matching “tuberculosis”
Characterization of A Novel Regulatory Protein in M. tuberculosis
$218,870Adel M Talaat · University Of Wisconsin-Madison · R21 · FY2011 · AI
Traffic from chronic mycobacterium induced granulomas
$218,870Matyas Sandor · University Of Wisconsin-Madison · R21 · FY2009 · AI
Emerging Infectious Disease Scholars at Brown University
$218,766Timothy P Flanigan · Brown University · R25 · FY2018 · AI
Emory/Georgia TB Research Advancement Center (TRAC)
$218,760Henry M Blumberg · Emory University · P30 · FY2023 · AI
Clinical Decision Support to Promote Immigrant Child Health Screening
$218,740Katherine M Yun · Children'S Hosp Of Philadelphia · R21 · FY2023 · AI
A multi-scale and multi-system approach to understand granuloma formation in TB
$218,734Jennifer Jean Linderman · University Of Michigan At Ann Arbor · R33 · FY2009 · HL
Discovery and validation of drug targets in vulnerable pathways of Mtb
$218,623David Alland · Rbhs-New Jersey Medical School · R21 · FY2014 · AI
Discovery and validation of drug targets in vulnerable pathways of Mtb
$218,623David Alland · Rbhs-New Jersey Medical School · R21 · FY2015 · AI
Emory/Georgia TB Research Advancement Center (TRAC)
$218,606Cheryl Liane Day · Emory University · P30 · FY2025 · AI
Development of TB cell wall biogenesis inhibitors
$218,578University Of Tennessee Health Sci Ctr · R21 · FY2003 · AI
GROWTH ACTIVATING FACTOR FOR MYCOBACTERIUM TUBERCULOSIS
$218,482Mycos Research, Llc · R43 · FY2001 · AI
FEND for TB supplement to accelerate BLINK X development
$218,451Jerrold J. Ellner · Rbhs-New Jersey Medical School · U01 · FY2022 · AI
Rapid Initiation of Antiretroviral Therapy to Promote Early HIV/AIDS Treatment in
$218,432Sydney Rosen · Boston University Medical Campus · U01 · FY2014 · AI
Modeling the impact and cost-effectiveness of opioid agonist treatments to reduce the negative consequences of incarceration on HIV and TB transmission in Eastern Europe and Central Asia
$218,421Frederick Lewis Altice · Yale University · R21 · FY2020 · DA
Mechanisms of Cochlear Oxidative Stress Injury and Strategies to Protect Hearing
$218,389Michael J. Brenner · University Of Michigan At Ann Arbor · K08 · FY2013 · DC
Immunity to TB in highly immunosuppressed HIV-infected and uninfected individuals
$218,384Anne Goldfeld · Boston Children'S Hospital · R21 · FY2017 · AI
A multi-scale and multi-system approach to understand granuloma formation in TB
$218,363Jennifer Jean Linderman · University Of Michigan At Ann Arbor · R33 · FY2010 · HL
Clinical Epidemiology of Infectious Diseases
$218,361Julie Parsonnet · Stanford University · T32 · FY2020 · AI
Host proteins that interact with the BCG cell envelope
$218,307Mary Sloan Siegrist · University Of Massachusetts Amherst · R21 · FY2022 · AI
Induction of regulatory T cells by highly virulent isolates of M.tuberculosis
$218,295Diane Joyce Ordway · Colorado State University · R21 · FY2011 · AI
The role of monocytes in the pathology of severe malaria.
$218,294David G Russell · Michigan State University · U19 · FY2016 · AI
CORE--Biosafety Core
$218,287Zahra Toossi · Case Western Reserve University · P30 · FY2008 · AI
Project 2: Response to Treatment
$218,245David R Sherman · Seattle Children'S Hospital · U19 · FY2018 · AI
Multidisciplinary Training Program in Pediatric Pulmonary
$218,224Pamela L. Zeitlin · Johns Hopkins University · T32 · FY2011 · HL
Target-based chemotherapeutics development against Mycobacterium tuberculosis
$218,138Sudeshna Roy · University Of Mississippi · R21 · FY2020 · AI